SOX-1 antibodies in a patient with Crohn's disease: a case report.
Anti-SOX1 antibodies
Crohn’s disease
Paraneoplastic neurological syndromes
Journal
BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555
Informations de publication
Date de publication:
02 Nov 2022
02 Nov 2022
Historique:
received:
13
06
2022
accepted:
18
10
2022
entrez:
3
11
2022
pubmed:
4
11
2022
medline:
5
11
2022
Statut:
epublish
Résumé
The anti-SOX-1 antibodies have been mainly associated with Lambert-Eaton Myasthenic Syndrome (LETMS) and Small-Cell Lung Cancer (SCLC). In this report, we describe the interesting case of a patient with serum anti-SOX-1 antibodies and Crohn's Disease (CD) with ensuing neurological symptoms. A Caucasian 67-year-old female was admitted to the Emergency Department with seizures, vertigo, emesis, nausea, postural instability and recurrent falls, over a period of 10 days. She had been affected by Crohn's Disease since 1991. A CT scan failed to detect any ischemic or haemorrhagic lesion. A brain MRI revealed signs of leukoencephalopathy. Western blot analysis of her serum revealed a high titre of the onconeural antibody anti-SOX1, consistent with a neurological, cerebellar type, paraneoplastic syndrome. In spite of multiple efforts to unmask a possible underlying malignancy, no neoplastic lesion cropped up during hospitalization. Her clinical conditions progressively deteriorated, up to respiratory failure; a few days later she died, due to ensuing septic shock and Multiple Organ Failure. Our experience may usher and reveal a new role of anti-neural antibodies, so far reckoned an early indicator of associated malignancy, suggesting that neurological syndromes associated with such antibodies may complicate also chronic Gastrointestinal (GI) diseases. As of now, testing for anti-neuronal antibodies appeared unnecessary within the diagnostic assessment of gastroenterological disorders, which may lead to overlooking incident neurologic autoimmune diseases. Further exploration of such research hypothesis in clinical grounds appears intriguing.
Sections du résumé
BACKGROUND
BACKGROUND
The anti-SOX-1 antibodies have been mainly associated with Lambert-Eaton Myasthenic Syndrome (LETMS) and Small-Cell Lung Cancer (SCLC). In this report, we describe the interesting case of a patient with serum anti-SOX-1 antibodies and Crohn's Disease (CD) with ensuing neurological symptoms.
CASE PRESENTATION
METHODS
A Caucasian 67-year-old female was admitted to the Emergency Department with seizures, vertigo, emesis, nausea, postural instability and recurrent falls, over a period of 10 days. She had been affected by Crohn's Disease since 1991. A CT scan failed to detect any ischemic or haemorrhagic lesion. A brain MRI revealed signs of leukoencephalopathy. Western blot analysis of her serum revealed a high titre of the onconeural antibody anti-SOX1, consistent with a neurological, cerebellar type, paraneoplastic syndrome. In spite of multiple efforts to unmask a possible underlying malignancy, no neoplastic lesion cropped up during hospitalization. Her clinical conditions progressively deteriorated, up to respiratory failure; a few days later she died, due to ensuing septic shock and Multiple Organ Failure.
CONCLUSIONS
CONCLUSIONS
Our experience may usher and reveal a new role of anti-neural antibodies, so far reckoned an early indicator of associated malignancy, suggesting that neurological syndromes associated with such antibodies may complicate also chronic Gastrointestinal (GI) diseases. As of now, testing for anti-neuronal antibodies appeared unnecessary within the diagnostic assessment of gastroenterological disorders, which may lead to overlooking incident neurologic autoimmune diseases. Further exploration of such research hypothesis in clinical grounds appears intriguing.
Identifiants
pubmed: 36324062
doi: 10.1186/s12883-022-02923-8
pii: 10.1186/s12883-022-02923-8
pmc: PMC9628059
doi:
Substances chimiques
Autoantibodies
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
404Informations de copyright
© 2022. The Author(s).
Références
Brain. 2005 Apr;128(Pt 4):867-79
pubmed: 15705608
Neurology. 2001 Nov 27;57(10):1885-8
pubmed: 11723281
Gastroenterol Rep (Oxf). 2019 Aug;7(4):291-297
pubmed: 31413837
Arthritis Rheum. 2001 Dec;44(12):2862-9
pubmed: 11762947
J Clin Neurol. 2020 Oct;16(4):530-546
pubmed: 33029958
J Neurol Sci. 2016 Oct 15;369:342-346
pubmed: 27653921
Front Med (Lausanne). 2021 Sep 28;8:753367
pubmed: 34651004
J Am Acad Dermatol. 2009 Sep;61(3):486-504
pubmed: 19628303
Radiology. 1996 Apr;199(1):109-15
pubmed: 8633131
J Crohns Colitis. 2016 Feb;10(2):186-93
pubmed: 26507860
Gastroenterology. 2005 Sep;129(3):827-36
pubmed: 16143122
J Clin Invest. 2011 Sep;121(9):3412-24
pubmed: 21865647
Gastroenterol Hepatol (N Y). 2014 Sep;10(9):599-600
pubmed: 27551255
World J Gastroenterol. 2005 Dec 14;11(46):7227-36
pubmed: 16437620
PLoS One. 2016 Oct 13;11(10):e0163811
pubmed: 27736974
Gastroenterology. 2005 Sep;129(3):819-26
pubmed: 16143121
J Crohns Colitis. 2008 Dec;2(4):304-9
pubmed: 21172228
Radiology. 1996 Apr;199(1):117-22
pubmed: 8633132
JAMA. 2021 Mar 09;325(10):962-970
pubmed: 33687470
Thorac Cancer. 2020 Feb;11(2):465-469
pubmed: 31880403
J Neuroimmunol. 2010 Sep 14;226(1-2):177-80
pubmed: 20701982
Front Immunol. 2020 Jun 02;11:991
pubmed: 32655545
J Crohns Colitis. 2013 Oct;7(9):683-93
pubmed: 23083697
J Neurol Neurosurg Psychiatry. 2021 Jul;92(7):757-768
pubmed: 33649022
Orphanet J Rare Dis. 2007 May 04;2:22
pubmed: 17480225
J Rheumatol. 2003 Oct;30(10):2287-91
pubmed: 14528531
Ther Adv Neurol Disord. 2021 Feb 1;14:1756286420985323
pubmed: 33796141
Neurol Neuroimmunol Neuroinflamm. 2021 May 18;8(4):
pubmed: 34006622
Brain Nerve. 2010 Apr;62(4):301-8
pubmed: 20420169
World J Gastroenterol. 2014 Jul 21;20(27):8764-82
pubmed: 25083051
Community Oncol. 2010 May 1;7(5):219-224
pubmed: 21572897
World J Gastroenterol. 2006 Aug 14;12(30):4819-31
pubmed: 16937463
Inflamm Bowel Dis. 2011 Jan;17(1):471-8
pubmed: 20725943
Ther Adv Neurol Disord. 2011 Jul;4(4):237-48
pubmed: 21765874
Histopathology. 2012 Jun;60(7):1034-44
pubmed: 22008086
Inflamm Bowel Dis. 2008 Jun;14(6):738-43
pubmed: 18300281
Handb Clin Neurol. 2014;120:595-605
pubmed: 24365340
ACG Case Rep J. 2021 Jan 29;8(1):e00521
pubmed: 33532511
Neurogastroenterol Motil. 2018 Jun;30(6):e13292
pubmed: 29345029
J Pediatr Gastroenterol Nutr. 2008 Feb;46(2):124-33
pubmed: 18223370
Dev Biol. 2013 Oct 1;382(1):330-43
pubmed: 23644063